2007
DOI: 10.1055/s-2007-991150
|View full text |Cite
|
Sign up to set email alerts
|

Mitochondrial Complex I Encephalomyopathy and Cerebral 5-Methyltetrahydrofolate Deficiency

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
41
0
1

Year Published

2008
2008
2019
2019

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 47 publications
(42 citation statements)
references
References 11 publications
0
41
0
1
Order By: Relevance
“…The low CSF levels of 5MTHF in our patient can be explained by blocked transport across the blood-brain barrier due to the presence of FR autoantibodies as well as by increased utilization and catabolism of 5MTHF due to oxidative stress [16]. Another explanation may be a defective transport due to ATP depletion in the choroid plexus, as seen in Kearns-Sayre syndrome.…”
Section: Discussionmentioning
confidence: 61%
See 1 more Smart Citation
“…The low CSF levels of 5MTHF in our patient can be explained by blocked transport across the blood-brain barrier due to the presence of FR autoantibodies as well as by increased utilization and catabolism of 5MTHF due to oxidative stress [16]. Another explanation may be a defective transport due to ATP depletion in the choroid plexus, as seen in Kearns-Sayre syndrome.…”
Section: Discussionmentioning
confidence: 61%
“…However, the presence of folate receptor autoantibodies, oxidative stress and secondary inflammatory responses are able to block folate transfer across the choroid plexus to the CNS. Such primary and secondary forms of cerebral folate deficiency (CFD) with an encephalopathic symptomatology have extensively been described in the infantile-onset CFD syndrome [14], mitochondrial encephalopathies [15], Kearns-Sayre syndrome [16], Rett syndrome [17,18], and Aicardi-Goutières syndrome [19]. The use of antifolate drugs in rare inborn errors of metabolism like deficiency of dihydropteridine reductase, methylenetetrahydrofolate reductase, aromatic aminoacid decarboxylase and 3-phosphoglycerate dehydrogenase should be excluded [14].…”
Section: Discussionmentioning
confidence: 99%
“…Dichloroacetate can lower lactate level nonspecifically in mitochondrial disease [114] and may be useful for short treatment of severe acidotic episodes. Recent observations in a small number of patients have suggested that defective ATP-dependent cerebral folate transport may result in reduced CSF 5-methyltetrahydrofolate levels in some patients with mitochondrial disease, with detectable clinical improvement with oral folinic acid supplementation [115,116]. Potential future approaches to mitochondrial disease treatment have recently been reviewed [10 ,33 ].…”
Section: Prognosis and Managementmentioning
confidence: 99%
“…However, profound 5-MTHF deficiency was only detected in KSS. By contrast, CFD was less marked in those patients with clinically heterogeneous respiratory chain enzyme deficiencies, including one further reported patient with severe mitochondrial complex I deficiency presenting with low CSF folate values [37].…”
Section: Cerebral Folate Deficiency and Mitochondrial Disordersmentioning
confidence: 93%